Selonsertib (GS-4997)

製品コードS8292 バッチS829201

印刷

化学情報

Chemical Structure Synonyms N/A Storage
(From the date of receipt)		 3 years -20°C powder
1 years -80°C in solvent
化学式

C24H24FN7O
分子量 445.49 CAS No. 1448428-04-3
Solubility (25°C)* 体外 DMSO 75 mg/mL (168.35 mM)
Ethanol 50 mg/mL (112.23 mM)
Water Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明 Selonsertib (GS-4997) is a highly selective and potent once-daily oral ASK1 inhibitor with potential anti-inflammatory, antineoplastic and anti-fibrotic activities.
in vitro

Selonsertib (GS-4997) is a highly selective and potent once-daily oral ASK1 inhibitor with pIC50 of 8.3.
in vivo

An orally bioavailable inhibitor of apoptosis signal-regulating kinase 1 (ASK1), with potential anti-inflammatory, antineoplastic and anti-fibrotic activities. Upon oral administration, ASK1 inhibitor GS-4997 targets and binds to the catalytic kinase domain of ASK1 in an ATP-competitive manner, thereby preventing its phosphorylation and activation. This prevents the phosphorylation of downstream kinases, such as c-Jun N-terminal kinases (JNKs) and p38 mitogen-activated protein kinase (p38 MAPK). By preventing the activation of ASK1-dependent signal transduction pathways, GS-4997 prevents the production of inflammatory cytokines, down-regulates the expression of genes involved in fibrosis, suppresses excessive apoptosis and inhibits cellular proliferation[2].

プロトコル(参考用のみ)

細胞アッセイ 細胞株 Cell-free assays
濃度 8.3 (pIC50)
反応時間
実験の流れ
動物実験 動物モデル C57BL/6 mice
投薬量 15, 30, and 60 mg/kg
投与方法 i.p.

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

ER Stress-Activated HSF1 Governs Cancer Cell Resistance to USP7 Inhibitor-Based Chemotherapy through the PERK Pathway [ Int J Mol Sci, 2024, 25(5)2768] PubMed: 38474017
Co-targeting ASK1 and THRβ synergistically improves steatohepatitis and fibrosis in a MASH animal model [ Biochem Biophys Res Commun, 2024, 705:149739] PubMed: 38460439
Nitric oxide-induced ribosome collision activates ribosomal surveillance mechanisms [ Cell Death Dis, 2023, 14(7):467] PubMed: 37495584
Nitric oxide-induced ribosome collision activates ribosomal surveillance mechanisms [ Cell Death Dis, 2023, 14(7):467] PubMed: 37495584
Metabolic improvement and liver regeneration by inhibiting CXXC5 function for non-alcoholic steatohepatitis treatment [ Exp Mol Med, 2022, 54(9):1511-1523] PubMed: 36114279
Systematic analysis of the MAPK signaling network reveals MAP3K-driven control of cell fate [ Cell Syst, 2022, 13(11):885-894.e4] PubMed: 36356576
CCN6 improves hepatic steatosis, inflammation, and fibrosis in non-alcoholic steatohepatitis [ Liver Int, 2022, 10.1111/liv.15430] PubMed: 36156376
Glutathione S-transferase Mu 2 inhibits hepatic steatosis via ASK1 suppression [ Commun Biol, 2022, 5(1):326] PubMed: 35388144
Distinct developmental and degenerative functions of SARM1 require NAD+ hydrolase activity [ PLoS Genet, 2022, 18(6):e1010246] PubMed: 35737728
Proteasome dysfunction under compromised redox metabolism dictates liver injury in NASH through ASK1/PPARγ binodal complementary modules [ Redox Biol, 2021, 45:102043] PubMed: 34144391

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。